XML 56 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation and Employee Benefit Plan (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Fair Value Assumptions of Options Awarded
The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option-pricing model using the assumptions in the following table:

Year Ended December 31,
202220232024
Expected term (years)
6.1
1.4 - 6.1
6.1
Risk-free interest rate
0.3% - 2.2%
3.6% - 5.0%
4.3% - 4.4%
Expected volatility
48.6% - 58.4%
51.3% - 54.4%
51.8% - 52.7%
Expected dividend yield— — — 
Schedule of Stock Option Activity
A summary of stock option and RSU activity under the Plans was as follows (in millions, except per share amounts):

Outstanding
Stock Options
Outstanding
Restricted Stock Units
 Number of
Shares
Weighted-
Average
Exercise
Price
Number of
Shares
Weighted-
Average
Grant
Date Fair
Value
Balances as of December 31, 202222 $23.41 34 $77.07 
Granted115.15 12 122.84 
Increase in shares available for grant— — — — 
Exercised/Vested (16)5.37 (14)93.25 
Canceled— 98.60 (2)120.36 
Balances as of December 31, 202371.76 30 85.35 
Granted168.18 13 153.36 
Increase in shares available for grant— — — — 
Exercised/Vested(3)41.55 (11)119.00 
Canceled— — (2)143.07 
Balances as of December 31, 2024$93.53 30 $97.93 
 Number of
Shares
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life (years)
Aggregate
Intrinsic
Value
Options outstanding as of December 31, 2023$71.76 5.77$500 
Options exercisable as of December 31, 202360.89 5.11448 
Options outstanding as of December 31, 202493.53 5.43260 
Options exercisable as of December 31, 202480.55 4.69253 
Schedule of RSU Activity
A summary of stock option and RSU activity under the Plans was as follows (in millions, except per share amounts):

Outstanding
Stock Options
Outstanding
Restricted Stock Units
 Number of
Shares
Weighted-
Average
Exercise
Price
Number of
Shares
Weighted-
Average
Grant
Date Fair
Value
Balances as of December 31, 202222 $23.41 34 $77.07 
Granted115.15 12 122.84 
Increase in shares available for grant— — — — 
Exercised/Vested (16)5.37 (14)93.25 
Canceled— 98.60 (2)120.36 
Balances as of December 31, 202371.76 30 85.35 
Granted168.18 13 153.36 
Increase in shares available for grant— — — — 
Exercised/Vested(3)41.55 (11)119.00 
Canceled— — (2)143.07 
Balances as of December 31, 2024$93.53 30 $97.93 
 Number of
Shares
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life (years)
Aggregate
Intrinsic
Value
Options outstanding as of December 31, 2023$71.76 5.77$500 
Options exercisable as of December 31, 202360.89 5.11448 
Options outstanding as of December 31, 202493.53 5.43260 
Options exercisable as of December 31, 202480.55 4.69253